The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Aquaporin‐4 Antibodies (NMO‐IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
Open accessAbstract
Antibodies to aquaporin‐4 (called NMO‐IgG or AQP4‐Ab) constitute a sensitive and highly specific serum marker of neuromyelitis optica (NMO) that can facilitate the differential diagnosis of NMO and classic multiple sclerosis. NMO‐IgG/AQP4‐Ab seropositive status has also important prognostic and therapeutic implications in patients with isolated longitudinally extensive myelitis (LETM) or optic neuritis (ON). In this article, we comprehensively review and critically appraise the existing literature on NMO‐IgG/AQP4‐Ab testing. All available immunoassays—including tissue‐based (IHC), cell‐based (ICC, FACS) and protein‐based (RIPA, FIPA, ELISA, W estern blotting) assays—and their differential advantages and disadvantages are discussed. Estimates for sensitivity, specificity, and positive and negative likelihood ratios are calculated for all published studies and accuracies of the various immunoassay techniques compared. Subgroup analyses are provided for NMO, LETM and ON, for relapsing vs. monophasic disease, and for various control groups (eg, MS vs. other controls). Numerous aspects of NMO‐IgG/AQP4‐Ab testing relevant for clinicians (eg, impact of antibody titers and longitudinal testing, indications for repeat testing, relevance of CSF testing and subclass analysis, NMO‐IgG/AQP4‐Ab in patients with rheumatic diseases) as well as technical aspects (eg, AQP4‐M1 vs. AQP4‐M23‐based assays, intact AQP4 vs. peptide substrates, effect of storage conditions and freeze/thaw cycles) and pitfalls are discussed. Finally, recommendations for the clinical application of NMO‐IgG/AQP4‐Ab serology are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Diagnostic tests 4: likelihood ratios
Deeks, J. J., & Altman, D. G. (2004) · BMJ · doi:10.1136/bmj.329.7458.168 · Cited by 1,600
Diagnostic criteria for multiple sclerosis
Poser, C. M., & Brinar, V. V. (2001) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(00)00125-6 · Cited by 1,283
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Self-citationNeuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
Pittock, S. J., Weinshenker, B. G., Lucchinetti, C. F., Wingerchuk, D. M., Corboy, J. R., & Lennon, V. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.964 · Cited by 701
Brain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
Paty, D. W., Oger, J. J. F., Kastrukoff, L. F., Hashimoto, S. A., Hooge, J. P., Eisen, A. A., Eisen, K. A., Purves, S. J., Low, M. D., Brandejs, V., et al. (1988) · Neurology · doi:10.1212/wnl.38.2.180 · Cited by 639
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
Weinshenker, B. G., Wingerchuk, D. M., Vukusic, S., Linbo, L., Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2006) · Annals of Neurology · doi:10.1002/ana.20770 · Cited by 588
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Self-citationMyelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Self-citationAQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
Self-citationImplications of the Aquaporin-4 Structure on Array Formation and Cell Adhesion
Hiroaki, Y., Tani, K., Kamegawa, A., Gyobu, N., Nishikawa, K., Suzuki, H., Walz, T., Sasaki, S., Mitsuoka, K., Kimura, K., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.081 · Cited by 386
NMO-IgG predicts the outcome of recurrent optic neuritis
Matiello, M., Lennon, V. A., Jacob, A., Pittock, S. J., Lucchinetti, C. F., Wingerchuk, D. M., & Weinshenker, B. G. (2008) · Neurology · doi:10.1212/01.wnl.0000303817.82134.da · Cited by 367
Jarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.038 · Cited by 361
Self-citationMechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
Self-citationCrystal structure of human aquaporin 4 at 1.8 Å and its mechanism of conductance
Ho, J. D., Yeh, R., Sandstrom, A., Chorny, I., Harries, W. E. C., Robbins, R. A., Miercke, L. J. W., & Stroud, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902725106 · Cited by 325
Palace, J., Leite, M. I., Nairne, A., & Vincent, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.188 · Cited by 322
CNS aquaporin-4 autoimmunity in children
McKeon, A., Lennon, V. A., Lotze, T., Tenenbaum, S., Ness, J. M., Rensel, M., Kuntz, N. L., Fryer, J. P., Homburger, H., Hunter, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000314832.24682.c6 · Cited by 322
Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms
Furman, C. S., Gorelick-Feldman, D. A., Davidson, K. G. V., Yasumura, T., Neely, J. D., Agre, P., & Rash, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235843100 · Cited by 315
Yamasaki, K., Kira, J., Kawano, Y., Kobayashi, T., Kanai, T., Nishimura, Y., Matsushita, S., Hasuo, K., & Tobimatsu, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400405 · Cited by 302
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 294
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 294
Self-citationEpidemiology of Neuromyelitis Optica in the United States: A Multicenter Analysis
Mealy, M. A., Wingerchuk, D. M., Greenberg, B. M., & Levy, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.314 · Cited by 286
The history of neuromyelitis optica
Jarius, S., & Wildemann, B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-8 · Cited by 279
Self-citationAmiry-Moghaddam, M., Frydenlund, D. S., & Ottersen, O. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.049 · Cited by 275
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Matsuoka, T., Matsushita, T., Kawano, Y., Osoegawa, M., Ochi, H., Ishizu, T., Minohara, M., Kikuchi, H., Mihara, F., Ohyagi, Y., et al. (2007) · Brain · doi:10.1093/brain/awm027 · Cited by 272
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
Ghezzi, A., Bergamaschi, R., Martinelli, V., Trojano, M., Tola, M. R., Merelli, E., Mancardi, L., Gallo, P., Filippi, M., Zaffaroni, M., et al. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0271-0 · Cited by 268
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, B., Tenembaum, S., Lennon, V. A., Ursell, E., Kennedy, J., Bar-Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000284600.80782.d5 · Cited by 263
Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG
Nakashima, I. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.080390 · Cited by 229
Neuromyelitis optica in France: A multicenter study of 125 patients
Collongues, N., Marignier, R., Zéphir, H., Papeix, C., Blanc, F., Ritleng, C., Tchikviladzé, M., Outteryck, O., Vukusic, S., Fleury, M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d31e35 · Cited by 213
Jarius, S., Probst, C., Borowski, K., Franciotta, D., Wildemann, B., Stoecker, W., & Wandinger, K. P. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.002 · Cited by 213
Self-citationJarius, S., Franciotta, D., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P. S., Reuss, R., Probst, C., Kristoferitsch, W., Wandinger, K. P., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-52 · Cited by 209
Self-citationAntibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
Paul, F., Jarius, S., Aktas, O., Bluthner, M., Bauer, O., Appelhans, H., Franciotta, D., Bergamaschi, R., Littleton, E., Palace, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040133 · Cited by 208
Self-citationImmunosuppressive therapy is more effective than interferon in neuromyelitis optica
Papeix, C., Vidal, J.-S., Seze, J. D., Pierrot-Deseilligny, C., Tourbah, A., Stankoff, B., Lebrun, C., Moreau, T., Vermersch, P., Fontaine, B., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070732 · Cited by 204
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients
Leite, M. I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825644ff · Cited by 203
Self-citationPosterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
Magaña, S. M., Matiello, M., Pittock, S. J., McKeon, A., Lennon, V. A., Rabinstein, A. A., Shuster, E., Kantarci, O. H., Lucchinetti, C. F., & Weinshenker, B. G. (2009) · Neurology · doi:10.1212/01.wnl.0000343001.36493.ae · Cited by 202
Crane, J. M., Lam, C., Rossi, A., Gupta, T., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227298 · Cited by 197
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
Shimizu, J., Hatanaka, Y., Hasegawa, M., Iwata, A., Sugimoto, I., Date, H., Goto, J., Shimizu, T., Takatsu, M., Sakurai, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8832e · Cited by 188
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis
Rostasy, K., Mader, S., Schanda, K., Huppke, P., Gärtner, J., Kraus, V., Karenfort, M., Tibussek, D., Blaschek, A., Bajer-Kornek, B., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2956 · Cited by 182
NMO-IgG in the diagnosis of neuromyelitis optica
Jarius, S., Franciotta, D., Bergamaschi, R., Wright, H., Littleton, E., Palace, J., Hohlfeld, R., & Vincent, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256822.01222.bd · Cited by 181
Self-citationWarabi, Y., Matsumoto, Y., & Hayashi, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.10.008 · Cited by 174
Spectrum of Pediatric Neuromyelitis Optica
Lotze, T. E., Northrop, J. L., Hutton, G. J., Ross, B., Schiffman, J. S., & Hunter, J. V. (2008) · Pediatrics · doi:10.1542/peds.2007-2758 · Cited by 172
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Jarius, S., Frederikson, J., Waters, P., Paul, F., Akman-Demir, G., Marignier, R., Franciotta, D., Ruprecht, K., Kuenz, B., Rommer, P., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.011 · Cited by 170
Self-citationAquaporin‐4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies
Nicchia, G. P., Mastrototaro, M., Rossi, A., Pisani, F., Tortorella, C., Ruggieri, M., Lia, A., Trojano, M., Frigeri, A., & Svelto, M. (2009) · Glia · doi:10.1002/glia.20855 · Cited by 166
Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Ishii, N., & Itoyama, Y. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.210.307 · Cited by 165
Rostasy, K. M., Mader, S., Hennes, E. M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512470310 · Cited by 163
Jarius, S., Jacobi, C., de Seze, J., Zephir, H., Paul, F., Franciotta, D., Rommer, P., Mader, S., Kleiter, I., Reindl, M., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511403958 · Cited by 162
Self-citationPatterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
Mader, S., Lutterotti, A., Pauli, F. D., Kuenz, B., Schanda, K., Aboul‐Enein, F., Khalil, M., Storch, M. K., Jarius, S., Kristoferitsch, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010455 · Cited by 160
Self-citationTakahashi, T., Miyazawa, I., Misu, T., Takano, R., Nakashima, I., Fujihara, K., Tobita, M., & Itoyama, Y. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.145391 · Cited by 158
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
Nishiyama, S., Ito, T., Misu, T., Takahashi, T., Kikuchi, A., Suzuki, N., Jin, K., Aoki, M., Fujihara, K., & Itoyama, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a82621 · Cited by 150
McKeon, A. B., Lennon, V. A., Jacob, A., Matiello, M., Lucchinetti, C. F., Kale, N., Chan, K. H., Weinshenker, B. G., Apiwattinakul, M., Wingerchuk, D. M., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21197 · Cited by 148
Jarius, S., Paul, F., Franciotta, D. M., Seze, J. D., Münch, C., Salvetti, M., Ruprecht, K., Liebetrau, M., Wandinger, K. P., Akman‐Demir, G., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431728 · Cited by 140
Self-citationYoshimura, S., Isobe, N., Matsushita, T., Yonekawa, T., Masaki, K., Sato, S., Kawano, Y., & Kira, J. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302925 · Cited by 139
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution
Bizzoco, E., Lolli, F., Repice, A. M., Hakiki, B., Falcini, M., Barilaro, A., Taiuti, R., Siracusa, G., Amato, M. P., Biagioli, T., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5171-x · Cited by 135
Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis
Petzold, A., Pittock, S. J., Lennon, V. A., Maggiore, C., Weinshenker, B. G., & Plant, G. T. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.146894 · Cited by 135
Cree, B., Goodin, D. S., & Hauser, S. L. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36534 · Cited by 135
Kim, S., Kim, W., Huh, S., Lee, K. Y., Jung, I. J., & Kim, H. J. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.1.36 · Cited by 134
Meurman, O., & Ziola, B. R. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.5.483 · Cited by 120
Hayakawa, S., Mori, M., Okuta, A., Kamegawa, A., Fujiyoshi, Y., Yoshiyama, Y., Mitsuoka, K., Ishibashi, K., Sasaki, S., Hattori, T., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.03.009 · Cited by 113
Tanaka, K., Tani, T., Tanaka, M., Saida, T., Idezuka, J., Yamazaki, M., Tsujita, M., Nakada, T., Sakimura, K., & Nishizawa, M. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507076976 · Cited by 111
Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
Sabater, L., Giralt, A., Boronat, A., Hankiewicz, K., Blanco, Y., Llufriú, S., Alberch, J., Graus, F., & Saiz, A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.014 · Cited by 102
for the Spanish–Italian NMO study group, Saiz, A., Zuliani, L., Blanco, Y., Tavolato, B. F., Giometto, B., & Graus, F. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0509-8 · Cited by 101
McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., Hinson, S. R., Kryzer, T. J., Lucchinetti, C. F., Weinshenker, B. G., Wingerchuk, D. M., Shuster, E. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.178 · Cited by 101
Uzawa, A., Mori, M., Hayakawa, S., Masuda, S., & Kuwabara, S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02897.x · Cited by 100
Bergamaschi, R., Tonietti, S., Franciotta, D. M., Candeloro, E., Tavazzi, E., Piccolo, G., Romani, A., & Cosi, V. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms988oa · Cited by 99
Wandinger, K., Stangel, M., Witte, T., Venables, P. J., Charles, P. J., Jarius, S., Wildemann, B., Probst, C., Iking‐Konert, C., & Schneider, M. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27337 · Cited by 97
Self-citationPolyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
Jarius, S., Franciotta, D. M., Bergamaschi, R., Rauer, S., Wandinger, K.-P., Petereit, H.-F., Mäurer, M., Tumani, H., Vincent, A. C., Eichhorn, P., et al. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.133330 · Cited by 97
Self-citationKalluri, S. R., Illés, Z., Srivastava, R., Cree, B., Menge, T., Bennett, J. L., Berthele, A., & Hemmer, B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.269 · Cited by 96
Crane, J., Bennett, J., & Verkman, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071670 · Cited by 92
Iorio, R., Fryer, J. P., Hinson, S. R., Fallier‐Becker, P., Wolburg, H., Pittock, S. J., & Lennon, V. A. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.07.008 · Cited by 88
Nakashima, I., Takahashi, T., Cree, B., Kim, H. J., Suzuki, C., Genain, C. P., Vincent, T., Fujihara, K., Itoyama, Y., & Bar‐Or, A. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.12.011 · Cited by 87
Kim, W., Lee, J. E., Li, X. F., Kim, S., Han, B.-G., Lee, B. I., Kim, J. K., Choi, K., & Kim, H. J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511424590 · Cited by 84
Jarius, S., Eichhorn, P., Jacobi, C., Wildemann, B., Wick, M. W., & Voltz, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.002 · Cited by 83
Self-citationNMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICA
Klawiter, E. C., Álvarez, E., Xu, J., Paciorkowski, A. R., Zhu, L., Parks, B. J., Cross, A. H., & Naismith, R. T. (2009) · Neurology · doi:10.1212/01.wnl.0000345066.57745.50 · Cited by 82
Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis
Scott, T. F. M., Kassab, S. L., & Pittock, S. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1398 · Cited by 77
Interferon-β1b Treatment in Neuromyelitis Optica
Tanaka, M., Tanaka, K., & Komori, M. (2009) · European Neurology · doi:10.1159/000227277 · Cited by 76
Jarius, S., Franciotta, D. M., Paul, F., Bergamaschi, R., Rommer, P. S., Ruprecht, K., Ringelstein, M., Aktaş, O., Kristoferitsch, W., & Wildemann, B. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.002 · Cited by 75
Self-citationAntiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients
Fazio, R., Malosio, M. L., Lampasona, V., Feo, D. D., Privitera, D., Marnetto, F., Centonze, D., Ghezzi, A., Comı, G., Furlan, R., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106851 · Cited by 75
Jarius, S., Wandinger, K.-P., Borowski, K., Stoecker, W., & Wildemann, B. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.10.048 · Cited by 73
Self-citationRossi, A., Pisani, F., Nicchia, G. P., Svelto, M., & Frigeri, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069245 · Cited by 73
Gluten sensitivity and neuromyelitis optica: two case reports
Jacob, S. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055491 · Cited by 71
Pisani, F., Mastrototaro, M., Rossi, A., Nicchia, G. P., Tortorella, C., Ruggieri, M., Trojano, M., Frigeri, A., & Svelto, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123000 · Cited by 71
Wildemann, B., Jarius, S., & Paul, F. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3602-x · Cited by 64
Self-citationMatsushita, T., Isobe, N., Piao, H. Z., Matsuoka, T., Ishizu, T., Doi, H., Masaki, K., Yoshiura, T., Yamasaki, R., Ohyagi, Y., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.009 · Cited by 63
Brain abnormalities in neuromyelitis optica
Kim, J., Kim, S., Ahn, S.-W., Lim, B. C., Chae, J., Hong, Y., Park, K. S., Sung, J., & Lee, K. W. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.12.001 · Cited by 59
Heerlein, K., Jarius, S., Jacobi, C., Rohde, S., Storch-Hagenlocher, B., & Wildemann, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.015 · Cited by 54
Self-citationChan, K. H., Kwan, J., Ho, P. W., Ho, J. W.-M., Chu, A. C. Y., & Ramsden, D. B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-50 · Cited by 53
Health, disability, and life insurance experiences of working-age persons with multiple sclerosis
Iezzoni, L. I., & Ngo, L. H. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071356 · Cited by 49
Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies
Ducray, F., Roos-Weil, R., Garcia, P.-Y., Slesari, J., Heinzlef, O., Chatelain, D., Toussaint, P., Roullet, E., & Honnorat, J. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.097972 · Cited by 48
Jarius, S., & Wildemann, B. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6355-8 · Cited by 47
Self-citationZávada, J., Nytrová, P., Wandinger, K. P., Jarius, S., Svobodová, R., Probst, C., Peterová, V., Tegzová, D., Pavelká, K., & Vencovský, J. (2011) · Rheumatology International · doi:10.1007/s00296-011-2176-4 · Cited by 45
Self-citationKetelslegers, I. A., Modderman, P. W., Vennegoor, A., Killestein, J., Hamann, D., & Hintzen, R. Q. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511412995 · Cited by 44
Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
Jarius, S., Franciotta, D. M., Bergamaschi, R., Wildemann, B., & Wandinger, K. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.127 · Cited by 43
Self-citationNeuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4
Jarius, S., Jacob, S., Waters, P. J., Jacob, A., Littleton, E. T., & Vincent, A. C. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.143263 · Cited by 43
Self-citationAntibodies against biotinylated proteins are present in normal human serum.
Dale, G. L., Gaddy, P., & Pikul, F. J. (1994) · PubMed · Cited by 42
NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy
Kay, C. S. K., Scola, R. H., Lorenzoni, P. J., Jarius, S., Arruda, W. O., & Werneck, L. C. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.038 · Cited by 42
Self-citationTani, T., Sakimura, K., Tsujita, M., Nakada, T., Tanaka, M., Nishizawa, M., & Tanaka, K. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.001 · Cited by 41
Diagnostik und Therapie der Neuromyelitis optica
(NEMOS), N. O. S., Trebst, C., Berthele, A., Jarius, S., Kümpfel, T., Schippling, S., Wildemann, B., & Wilke, C. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3192-4 · Cited by 38
Self-citationAn early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS
Jarius, S., & Wildemann, B. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511411758 · Cited by 36
Self-citationFine specificity of antibodies against AQP4: Epitope mapping reveals intracellular epitopes
Kampylafka, E. I., Routsias, J. G., Alexopoulos, H., Dalakas, M. C., Moutsopoulos, H. Μ., & Tzioufas, A. G. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.01.004 · Cited by 34
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica
Jarius, S., Lauda, F., Wildemann, B., & Tumani, H. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6755-4 · Cited by 33
Self-citationJarius, S., Paul, F., Ruprecht, K., & Wildemann, B. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6677-1 · Cited by 32
Self-citationUtility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders
Kim, S., Waters, P. J., Woodhall, M. R., Kim, J., Kim, J., Yang, J. W., Kim, J.-S., Sung, J., Park, K. S., & Lee, K. W. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512472748 · Cited by 32
‘Noteomielite’ accompanied by acute amaurosis (1844).
Jarius, S., & Wildemann, B. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.025 · Cited by 26
Self-citationOn the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica
Jarius, S., & Wildemann, B. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6594-3 · Cited by 26
Self-citationVidi, I. D., Boursier, G., Delouche, N., Portalès, P., Cadars, E., Bouthier, M., Mettling, C., Lin, Y., Thouvenot, É., Carlander, B., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.012 · Cited by 25
Granieri, L., Marnetto, F., Valentino, P., Frau, J., Patanella, A. K., Nytrova, P., Sola, P., Capobianco, M., Jarius, S., & Bertolotto, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038896 · Cited by 24
Self-citationDiagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients
Apiwattanakul, M., Asawavichienjinda, T., Pulkes, T., Tantirittisak, T., Hemachudha, T., Horta, E. S., Jenkins, S. M., & Pittock, S. J. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.014 · Cited by 24
Kim, Y., Jung, S., Kim, Y., Park, Y.-J., Han, K., & Oh, E. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21508 · Cited by 20
Zhang, X., Shu, H., Zhang, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055772 · Cited by 17
An early British case of neuromyelitis optica (1850)
Jarius, S., & Wildemann, B. (2012) · BMJ · doi:10.1136/bmj.e6430 · Cited by 15
Self-citationBergamaschi, R. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0092-4 · Cited by 14
Smith, C. H., Waubant, E. L., & Langer-Gould, A. M. (2009) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e3181a63606 · Cited by 11
Jarius, S., & Wildemann, B. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2262-8 · Cited by 10
Self-citationEffect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels
Jarius, S., & Wildemann, B. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.717 · Cited by 9
Self-citationComment: Sensitivity and clinical relevance of available anti-aquaporin-4 antibody assays
Fujihara, K. (2012) · Neurology · doi:10.1212/wnl.0b013e318248df85 · Cited by 1
Cited by
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Self-citationMOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R. C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H. J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1144-2 · Cited by 747
Self-citationNeuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595
Self-citationJarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Self-citation
Metadata
- Authors
- Jarius, S., & Wildemann, B.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2013-10-14
- Volume
- 23
- Issue
- 6
- Pages
- 661-683
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2152156112
- Cited by
- 254
- References
- 130
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.